<!DOCTYPE HTML>
<html>
<head>
	<meta charset="UTF-8">
	<title>About - Laboratory Website Template</title>
	<link rel="stylesheet" href="css/style.css" type="text/css">
</head>
<body>
	<div id="header">
		<a href="index.html"><img src="images/logo.png" alt=""></a>
		<ul>
			<li>
				<a href="index.html">home</a>
			</li>
			<li class="selected">
				<a href="team.html">team</a>
			</li>
			<li>
				<a href="research.html">research</a>
			</li>
			<li>
				<a href="publication.html">publication</a>
			</li>
			<li>
				<a href="news.html">news</a>
			</li>
			<li>
				<a href="contact.html">contact</a>
			</li>
		</ul>
    </li>
   </ul>
  <!-- /top menu -->
  </nav>
 </header>
</div> 
<div class="content_block">
 <!-- top_title -->
 
 </div>
 <!-- /top_title -->
 <div class="wraper">
  <!-- team_option -->
  <div class="team_option">
   <h4>Meet the PhD supervisor</h4>
   <ul>
    <li>
     <div class="img bwWrapper"><img src="images/meet_the_team/2.1.png" width="278" height="300" alt="" /><p><strong>Prof. Haiping Hao</strong></p></div>
     <div class="desc">
      <ul class="social">
       
      </ul>
      <p><strong>AFFILIATION</strong></p>
      <p> State Key Laboratory of Natural Medicines.

             <br/>Key Lab of Drug Metabolism and Pharmacokinetics,<br/> China Pharmaceutical University, Nanjing, 210009, P. R. of China. <br/><strong>E-mail:</strong> haipinghao@cpu.edu.cn
<br/><br/><strong>RESEARCH INTERESTS：</strong> Pharmacokinetics, pharmacology, metabolomics, immune metabolism, metabolic regulation and target discovering</p>
     
   <ul>
    <li>
      <p><strong>EDUCATION</strong></p>
      <p>Aug 2012~Aug 2013, NIH/NCI, visiting scholar;<br/>Sep 2003~Jun 2006, China Pharmaceutical university, Ph.D of pharmacology;<br/>Sep 2000～Jun 2003, Nanjing University of Traditional Chinese Medicine, Master of TCM;
             </p>

<p><strong>WORKING EXPERIENCE </strong></p>
      <p>Aug 2019 to now, Vice President, China Pharmaceutical University;<br/>
July 2015 to July 2019, Dean of School of Pharmacy, China Pharmaceutical University;<br/>
Jan 2013 to now, Associated Director of State Key Laboratory of Nature Medicine, China Pharmaceutical University;<br/>
July 2011 to now, Key lab of Drug Metabolism & Pharmacokinetics, China Pharmaceutical University, Professor;<br/>
Jun 2006~Jun 2011, Key lab of Drug Metabolism & Pharmacokinetics, China Pharmaceutical University, Associate Professor;<br/>
Sep 1994~Aug 2000, Wangjiang Hospital of Traditional Chinese Medicine, Anhui Province, P.R. China, pharmacist of TCM.
</p>
<p><strong>AWARDS</strong></p>
<p>2013, The National Science Foundation for Distinguished Young Scholars of China;<br/>
2014, "Changjiang Scholar" distinguished professor by The Ministry of Education;<br/>
2008, The winner of the TOP 100 excellent doctoral dissertation in China;<br/>
Prof. Hao was also the winner of the Program for New Century Excellent Talents in University by Ministry of Education, the second class of Jiangsu "333" high level talent training project for young people in science and technology, the foundation for the Distinguished Young Scholars of Jiangsu Province , and the winner of 11th Ten Young Stars of Jiangsu Science and Technology.<p>
<br/>
<strong>RESEARCH INTERESTS</strong>
<p>Focusing on metabolic regulation of endogenous substances, discovery and validation of drug targets, as well as mechanism of action for nature medicines, Dr. Hao has built systematic and universal quali-/quantitative methods for complex TCM components analysis, while providing theoretical and practical solution for studying of DMPK for nature medicine with multi-component and multi-target characteristics. Based on revealing the pattern for metabolism and disposition of natural active components by organism, he proposed theories of “Reverse Pharmacokinetics” and “DMPK-directed discovery of drug target and mechanism”, which have contributed to research of endogenous bioactive substances such as bile acids and tryptophan.<p>
<p><strong>ACHIEVEMENTS</strong><p>
<p>Prof. Hao has been in charge of totally 17 significant projects of scientific research, including National Projects of Innovative Drugs, Major/International Cooperative Projects of Natural Science Foundation of China and National Science Fund for Distinguished Young Scholars. As main participant, he has twice won the silver medal of National Scientific and Technological Progress Award (ranked third and fourth, respectively), and gold medal of MOE Scientific and Technological Progress in 2012 (ranked second). Prof. Hao has published ~200 SCI papers, and over 70 of these research papers were published on top journals as first or corresponding author, including Cell Metabolism, Nature Communication, Trends in Pharmacological Science, Analytical Chemistry and Drug Metabolism and Disposition.<p>
<p><strong>SELECTED PUBLICATIONS</strong><p>
<p>•Zhou JY, Cui S, He QX, Guo YT, Pan XJ, Zhang PF, Huang NN, Ge CL, Wang GJ, Gonzalez FJ, Wang H*, <b>Hao HP*</b>. SUMOylation inhibitors synergize with FXR agonists in combating liver fibrosis. Nat commun. 2020 Jan 13, 11(1): 240.<br/>
•Liu YL, Hou YL, Wang GJ, Zheng X*, <b>Hao HP*</b>. Gut Microbial Metabolites of Aromatic Amino Acids as Signals in Host-Microbe Interplay. Trends Endocrinol Metab. 2020 Apr 10;s1043-2760(20)30054-0.<br/>
•Li QR#, Cao LJ#, Tian Y, Zhang P, Ding CJ, Lu WJ, Jia CX, Shao C, Liu WY, Wang D, Ye H*, <b>Hao HP*</b>. Butyrate Suppresses the Proliferation of Colorectal Cancer Cells via Targeting Pyruvate Kinase M2 and Metabolic Reprogramming. Mol Cell Proteomics. 2018 Aug;17(8):1531-1545.<br/>
•<b>Hao H#</b>, Cao L#, Jiang C#, Che Y, Zhang S, Takahashi S, Wang G*, Gonzalez FJ*. Farnesoid X Receptor Regulation of the NLRP3 Inflammasome Underlies Cholestasis-Associated Sepsis. Cell Metab. 2017 Apr 4;25(4):856-867.<br/>
•Wang L#, Ye H#, Sun D, Meng T, Cao L, Wu M, Zhao M, Wang Y, Chen B, Xu X, Wang G*, <b>Hao H*</b>. A Metabolic Pathway Extension Approach for Metabolomic Biomarker Identification. Anal Chem. 2017 Jan 17;89(2):1229-1237.<br/>
•Zheng X, Zhang X, Wang G*, <b>Hao H*</b>. Treat the brain and treat the periphery: toward a holistic approach to major depressive disorder. Drug Discov Today. 2015 May; 20(5):562-8.<br/>
•Zhou X, Cao L, Jiang C, Xie Y, Chen X, Krausz KW, Qi Y, Sun L, Shah YM, Gonzalez FJ, Wang G*,<b> Hao H*</b>. PPARα-UGT axis activation represses intestinal FXR-FGF15 feedback signalling and exacerbates experimental colitis. Nat Commun, 2014, 5:4573.<br/>
•<b>Hao H</b>, Zheng X, Wang G*. Insights to drug discovery from natural medicines using reverse pharmacokinetics. Trends Pharmacol Sci, 2014, 35(4):168-177.<br/>
<p>

     </div>
    </li>
   </ul>
  </div>
 <!-- /team_option -->
 <!-- team_option2 -->
  <div class="team_option team_option2">
   <h4>Meet the Group </h4>
  <ul>
    <li>
     <div class="img bwWrapper"><img src="images/meet_the_team/meet_team_2.1.png" width="407" height="227" alt="" /></div>
     <div class="desc">
      <ul class="social">
      
       </ul>
	  <p><strong>Dr. Lijuan Cao</strong><br/>Assiociate research fellow<br/><br/><strong>E-mail:</strong> caolijuan0702@cpu.edu.cn</p>
                  <p><strong>EDUCATION</strong></p>
      <p><strong>Ph.D. </strong>     in Pharmacokinetics (Supervisor: Prof. Guangji Wang), June 2015<br/>College of Pharmacy, China Pharmaceutical University, Jiangsu, Nanjing, P. R. China <br/>
             <strong>B.S.  </strong>      in Base class of Pharmaceutical Science, <br/>June 2010 College of Pharmacy, China Pharmaceutical University, Jiangsu, Nanjing, P. R. China </p>
      <strong>EXPERTISE AND RESEARCH INTERESTS </strong><br/><br/>
      <p>Research interest focus on metabolism-immune crosstalk, cell fate decision in sensing metabolic disorders and new drug targets discovering.</p>
     </div>
    </li>
    <li>
     <div class="img bwWrapper"><img src="images/meet_the_team/meet_team_2.2.png" width="407" height="227" alt="" /></div>
     <div class="desc">
      <ul class="social">
       
      </ul>
	  <p><strong>Dr. Hong Wang</strong><br/>Associate Prof.<br/><br/><strong>E-mail:</strong> wanghong@cpu.edu.cn</p>
                  <p><strong>EDUCATION</strong></p>
      <p><strong>Ph.D. </strong>     Drug Metabolism and Pharmacokinetics major (Supervisor: Prof. Guangji Wang), June 2015<br/>School of Pharmacy, China Pharmaceutical University, Nanjing, China<br/>
             <strong>B.S.  </strong>      Pharmacy major, June 2010<br/>College of Pharmacy, Chongqing Medical University, Chongqing, China</p>
      <strong>EXPERTISE AND RESEARCH INTERESTS </strong><br/><br/>
      <p>1.Physio-pathological function and dynamic regulation oriented therapeutic strategy propose and drug development targeting nuclear receptors.<br/>
             2.Effect evaluation and mechanism exploration of tradition Chinese medicines for nonalcoholic fatty liver disease and fibrosis.</p>
     </div>
    </li>
   </ul>
  </div>
  <!-- /team_option2 -->
 <!-- /team_option -->
  <!-- team_option2 -->
  <div class="team_option team_option2">
    <ul>
    <li>
     <div class="img bwWrapper"><img src="images/meet_the_team/meet_team_2.3.png" width="407" height="227" alt="" /></div>
     <div class="desc">
      <ul class="social">
      
      </ul>
	  <p><strong>Dr. Xiao Zheng</strong><br />Associate Prof.<br/><br/><strong>E-mail:</strong>xzheng@cpu.edu.cn</p>
      <p><strong>EDUCATION</strong></p>
      <p><strong>Ph.D. </strong>     in Pharmacokinetics (Supervisor: Prof. Guangji Wang),  June 2013<br/>China Pharmaceutical University, Nanjing, Jiangsu, China<br/>
             <strong>B.S.  </strong>       in Basic Pharmacy,  June 2008<br/>China Pharmaceutical University, Nanjing, Jiangsu, China</p>
<strong>EXPERTISE AND RESEARCH INTERESTS </strong><br/><br/>
      <p>We are interested in metabolic regulation of gut-brain crosstalk, in particular the signaling metabolites and downstream molecular pathway underlying diseases such as depressive disorder and irritable bowel disease. Based on the use of multi-omics, optogenetics and germ free animals, our research particularly focuses on how host and microbial metabolism of diet and drugs regulate neural and immune responses along the gut-brain axis, and their relevance to the pathogenesis of gut-brain disorders and treatment.
</p>
     </div>
    </li>
    <li>
     <div class="img bwWrapper"><img src="images/meet_the_team/meet_team_2.4.png" width="407" height="227" alt="" /></div>
     <div class="desc">
      <ul class="social">
       
        </ul>
	  <p><strong>Dr. Hui Ye</strong><br />Associate Prof.<br/><br/><strong>E-mail:</strong> cpuyehui@cpu.edu.cn</p>
      <p><strong>EDUCATION</strong></p>
      <p><strong>Ph.D. </strong>     Pharmaceutical Science major (Supervisor: Prof. Lingjun Li), May 2013 <br/>School of Pharmacy, University of Wisconsin-Madison, Madison, WI, USA<br/>
             <strong>B.S.  </strong>        Chemistry major, June 2008 <br/>Sichuan University, Chengdu,  Sichuan, P. R. China</p>
<strong>EXPERTISE AND RESEARCH INTERESTS </strong><br/><br/>
      <p>Metabolomics, chemical proteomics, metabolite-protein interactions<br/><br/>
My research focuses on developing and implementing an array of novel analytical tools in the area of metabolomics and chemical proteomics to elucidate the direct binding targets of small molecules including natural medicines and endogenous metabolites, and gain new insights into how these functional molecules regulate protein function and signaling network. The gained knowledge is thus utilized to design and synthesize novel ligands that allow modulating the structures and hence the activities of the target proteins that are intimately associated with diseases such as cancer and immune diseases. 
</p>
     </div>
    </li>
   </ul>
  </div>
  <!-- /team_option2 -->
<!-- /team_option -->
  <!-- team_option2 -->
  <div class="team_option team_option2">
   
   <ul>
    <li>
     <div class="img bwWrapper"><img src="images/meet_the_team/meet_team_2.5.png" width="407" height="227" alt="" /></div>
     <div class="desc">
      <ul class="social">
      
      </ul>
	  <p><strong>Dr. Qiuling Zheng</strong><br />Associate Prof.<br/><br/><strong>E-mail:</strong> qiuling_zheng@cpu.edu.cn</p>
      <p><strong>EDUCATION</strong></p>
      <p><strong>Ph.D. </strong>     Chemistry (Supervisor: Prof. Hao Chen), Ohio University, Athens, OH, USA 2013.08-2016.04<br/>
             <strong>M.S.  </strong>     Chemistry (Supervisor: Prof. Hao Chen), Ohio University, Athens, OH, USA 2011.09-2013.05<br/>
             <strong>B.S.  </strong>      Pharmacy, China Pharmaceutical University, Nanjing, Jiangsu, China 2007.09-2011.06</p>
<strong>EXPERTISE AND RESEARCH INTERESTS </strong><br/><br/>
      <p>Research interest focuses on the protein conformational analysis and method development for proteomics.
</p>
     </div>
    </li>
    <li>
     <div class="img bwWrapper"><img src="images/meet_the_team/meet_team_2.6.png" width="407" height="227" alt="" /></div>
     <div class="desc">
      <ul class="social">
       
       </ul>
	  <p><strong>Dr. Huiyong Sun</strong><br />Associate Prof.<br/><br/><strong>E-mail:</strong> huiyongsun@cpu.edu.cn</p>
      <p><strong>EDUCATION</strong></p>
      <p><strong> Postdoc. </strong>     Computational Science (Co-Supervisor: Tingjun Hou), 2015-2018,<br/> College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China<br/>
             <strong>Ph.D.  </strong>          Chemical Biology (Supervisor: Tingjun Hou), 2012-2015,<br/> Institute of Functional Nano & Soft Materials (FUNSOM), Soochow University, Suzhou, China 
</p>
<strong>EXPERTISE AND RESEARCH INTERESTS </strong><br/><br/>
      <p>Metabolomics, chemical proteomics, metabolite-protein interactions<br/><br/>
My research interest focus on computer-aided drug design (CADD), including accurate binding free energy prediction and artificial intelligence for various drug design issues.
</p>
     </div>
    </li>
   </ul>
  </div>
  <!-- /team_option2 -->
<!-- /team_option -->
  <!-- team_option2 -->
  <div class="team_option team_option2">
 <ul>
    <li>
     <div class="img bwWrapper"><img src="images/meet_the_team/meet_team_2.7.png" width="407" height="227" alt="" /></div>
     <div class="desc">
      <ul class="social">
</ul>
	  <p><strong>Dr. Xiaowei Xu</strong><br />Associate Prof.<br/><br/><strong>E-mail:</strong> xw@cpu.edu.cn</p>
      <p><strong>EDUCATION</strong></p>
      <p><strong>Ph.D. </strong>      Chemical Biology (Supervisor: Prof. Xiang Zhou), June 2015<br/>College of Chemistry and Molecular Sciences, Wuhan University, Hubei, Wuhan, P. R. China <br/>
             <strong>B.S.  </strong>        Chemistry, June 2010 <br/>School of Chemistry and Materials Science, <br/>University of Science and Technology of China, Anhui, Hefei, P. R. China
</p>
<strong>EXPERTISE AND RESEARCH INTERESTS </strong><br/><br/>
      <p>My research interest focus on Medicinal Chemistry and Chemical Biology about probe design and new target discovery.</p>
     </div>
    </li>
   </ul>
  </div>
  <!-- /team_option2 -->
<!-- /team_option2 -->
<!-- /team_option -->
  <!-- /team_option2 -->
  <!-- team_option2 -->
  <div class="team_option team_option2">
   <h4>Meet the Postdoc </h4>
   <ul>
    <li>
     <div class="img bwWrapper"><img src="images/meet_the_team/meet_team_3.1.png" width="412" height="227" alt="" /></div>
     <div class="desc">
      <ul class="social">
      
      </ul>
	  <p><strong>Dr. Dong Wang</strong><br />Postdoctoral Fellow</p>
      <p><strong>EDUCATION</strong></p>
      <p><strong>Ph.D. </strong>    in Biology (Supervisor: Ke Zen), <br />September 2017 School of Life Sciences, Nanjing University, Nanjing, Jiangsu, P. R. China<br/>
             <strong>B.S.  </strong>        Biotechnology major, June 2012<br /> Nanjing Medical University, Nanjing, Jiangsu, P. R. China</p>
     <strong> RESEARCH INTERESTS </strong><br/><br/>
      <p>My research focuses on the regulation of metabolic enzymes/metabolites and host homeostasis in the gastrointestinal tract, especially the mechanism of the glycolytic kinase PKM2 regulates the immune and host balance of the intestine.</p>
</div>
</li>
    <li>
     <div class="img bwWrapper"><img src="images/meet_the_team/meet_team_3.2.png" width="412" height="227" alt="" /></div>
     <div class="desc">
      <ul class="social">
       
     </ul>
	  <p><strong>Dr. Wanfeng Xu</strong><br />Postdoctoral Fellow</p>
      <p><strong>EDUCATION</strong></p>
      <p><strong>Ph.D. </strong>    . in Pharmacokinetics (Supervisor: Prof. Haiping Hao), <br />June 2020 College of Pharmacy, China Pharmaceutical University, Jiangsu, Nanjing, P. R. China <br/>
             <strong>B.S.  </strong>       in Bio-pharmaceuticals, June 2015<br />College of Life Sciences and Technology, China Pharmaceutical University, Jiangsu, Nanjing, P. R. China </p>
     <strong> RESEARCH INTERESTS </strong><br/><br/>
      <p>Research interest focus on pyroptotic cell death signaling regulation in organ failure and drug discovery.</p>
     </div>
    </li>
   </ul>
  </div>
  <!-- /team_option2 -->
<!-- /team_option2 -->
  <!-- team_option2 -->
  <div class="team_option team_option2">
   <ul>
    <li>
     <div class="img bwWrapper"><img src="images/meet_the_team/meet_team_3.3.png" width="412" height="227" alt="" /></div>
     <div class="desc">
      <ul class="social">
      
      </ul>
	  <p><strong>Dr. Chang Shao</strong><br />Postdoctoral Fellow</p>
      <p><strong>EDUCATION</strong><br />2019-Current: Postdoctoral fellowship, school of Pharmacy, China Pharmaceutical University<br />2014-2019: Ph.D in pharmacokinetics, China Pharmaceutical University<br />2010-2014: B.S. in Pharmacy, China Pharmaceutical University</p>
      <p><strong>RESEARCH INTERESTS</strong><br />My current research focuses on cancer metabolism and the metabolic communication between cancer cells and other cell populations in tumor microenvironment.</p>
     </div>
</li>
    <li>
     <div class="img bwWrapper"><img src="images/meet_the_team/meet_team_3.4.png" width="412" height="227" alt="" /></div>
     <div class="desc">
      <ul class="social">
       
      </ul>
	  <p><strong>Dr. Yuanlong Hou</strong><br />Postdoctoral Fellow</p>
       <p><strong>EDUCATION</strong></p>
      <p><strong>Ph.D. </strong>    in Laboratory of Metabolism and Drug Target Discovery (Supervisor: Prof. Guangji Wang), State Key Laboratory of Natural Medicines, College of Pharmacy, China Pharmaceutical University, Nanjing, China<br/>
             <strong>B.S.  </strong>      in College of Animal Sciences and Technology, Qingdao Agricultural University, Qingdao, China.
</p>
     <strong> RESEARCH INTERESTS </strong><br/><br/>
      <p>Studies on microbial metabolomics and host-gut microbe-drug metabolic interactions that underlie the development of gastrointestinal diseases and drug effect and the treatment of these conditions using small molecule compounds.
</p>
     </div>
    </li>
   </ul>
  </div>
  <!-- /team_option2 -->
<!-- /team_option2 -->
  <!-- team_option2 -->
  <div class="team_option team_option2">
   <ul>
    <li>
     <div class="img bwWrapper"><img src="images/meet_the_team/meet_team_3.5.png" width="412" height="227" alt="" /></div>
     <div class="desc">
      <ul class="social">
      
       </ul>
	  <p><strong>Dr. Yun Wang</strong><br />Postdoctoral Fellow</p>
      <p><strong>EDUCATION</strong></p>
      <p><strong>Ph.D. </strong>    .in Pharmacokinetics (Supervisor: Prof. Guangji Wang), June 2021<br/> Institute of Pharmaceutical Sciences, China Pharmaceutical University, Jiangsu, Nanjing, P. R. China<br/>
             <strong>B.S.  </strong>      in Pharmaceutical Analysis, June 2015<br/>College of Pharmacy, China Pharmaceutical University, Jiangsu, Nanjing, P. R. China </p>
     <strong> RESEARCH INTERESTS </strong><br/><br/>
      <p>Research interest focus on microbiota-host crosstalk in chronic metabolic diseases and pharmacodynamic mechanism of Traditional Chinese Medicine.</p>
     </div>
</li>
    <li>
     <div class="img bwWrapper"><img src="images/meet_the_team/meet_team_3.6.png" width="412" height="227" alt="" /></div>
     <div class="desc">
      <ul class="social">
       
    </ul>
	  <p><strong>Dr. Shuang Cui</strong><br />Postdoctoral Fellow</p>
      <p><strong>EDUCATION</strong></p>
      <p><strong>Ph.D. </strong>    Pharmacokinetics major (Supervisor: Prof. Haiping Hao), June 2021 <br/>School of Pharmacy, China  Pharmaceutical  University, Nanjing, China.<br/>
             <strong> M.S. </strong>    Pharmacology major (Supervisor: Associate Prof. Guoqing Gong), June 2017 <br/>School of Pharmacy, China  Pharmaceutical  University, Nanjing, China.B.S. Pharmaceutics major, June 2014<br/>
             <strong> B.S.  </strong>   Pharmaceutics major, June 2014 <br/>Hebei University of Science and Technology, Shijiazhuang, China.
</p>
     <strong> RESEARCH INTERESTS </strong><br/><br/>
      <p>1.Dynamic process and regulatory mechanism of nuclear receptor superfamily in liver diseases.<br/>
2.Synergism and toxicity mechanism of FXR agonist in liver diseases.
</p>
     </div>
    </li>
   </ul>
  </div>
  <!-- /team_option2 -->
<!-- /team_option2 -->
<!-- /team_option2 -->
  <!-- team_option2 -->
  <div class="team_option team_option2">
   <h4>Meet the Technician </h4>
   <ul>
    <li>
     <div class="img bwWrapper"><img src="images/meet_the_team/meet_team_4.png" width="407" height="227" alt="" /></div>
     <div class="desc">
      <ul class="social">
      
     </ul>
	  <p><strong>M.M. Dandan He</strong><br />Assistant lab master<br/><br/><strong>E-mail:</strong>cpudandanhe@163.com</p>
      <p><strong>EDUCATION</strong></p>
      <p><strong>M.M. </strong>      in Pharmaceutical Analysis  (Supervisor: Prof. Daoquan Tang), July 2018<br /> Xuzhou Medical University, Xuzhou, Jiangsu, P.R. China<br/>
             <strong>B.S.  </strong>        in Pharmaceutical Preparation, July 2015<br /> Xuzhou Medical University, Xuzhou, Jiangsu, P.R. China</p>
<strong>EXPERTISE AND RESEARCH INTERESTS </strong><br/><br/>
      <p>My research interests are devoted to metabolic aspects, mainly including the study of hepatic drug enzyme activity as well as non-target metabolomics.<br />
1.Effect of different compatibility of traditional Chinese medicine on liver drug enzyme activity: we proposed a strategy to explore the compatibility mechanism of traditional Chinese medicine by investigating P450 enzymes-based metabolic interactions between monarch drugs and the other constituent herbs.<br />
2.Non-target metabolomics: liquid chromatography-mass spectrometry is used as a detection method to to identify differences between their metabolite profiles which may be relevant to specific biological conditions, and then studying these different  metabolites and physiological and pathological changes.

</p>
     </div>
<!-- /team_option2 -->
 
                        <span>&copy; 2021&nbspHao&nbspLab All Rights Reserved.
                  </p>
            </div>
 </div>
</div>
</body>
</html> 
 